SiNtx

$2.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.09 (+4.39%) As of 4:14 PM UTC today

Why Robinhood?

You can buy or sell SiNtx and other stocks, options, and ETFs commission-free!

About SINT

SINTX Technologies, Inc. operates as a commercial biomaterial company. It focuses on using silicon nitride technology platform to develop, manufacture and sell a range of medical devices. The firm markets spinal fusion products and develops products for use in total hip and knee joint replacements. Its FDA-cleared and CE-marked spine products are marketed in the U.S. and selected markets in Europe and South America. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in 1996 and is headquartered in Salt Lake City, UT. The listed name for SINT is SiNtx Technologies, Inc. Common Stock.

CEO
B. Sonny Bal
Employees
28
Headquarters
Salt Lake City, Utah
Founded
1996
Market Cap
47.90M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.35M
High Today
$2.18
Low Today
$2.09
Open Price
$2.12
Volume
555.42K
52 Week High
$3.44
52 Week Low
$0.28

SINT Earnings

-$1.46
-$0.97
-$0.49
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 24

You May Also Like

NS-B
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure